Infliximab is the drug we have been waiting for in Crohn's disease

被引：9
|
作者：
Rutgeerts, P [1 ]
机构：
[1] Univ Hosp Gasthuisberg, Dept Med, B-3000 Louvain, Belgium
来源：
INFLAMMATORY BOWEL DISEASES | 2000年 / 6卷 / 02期
关键词：
D O I：
10.1097/00054725-200005000-00010
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：132 / 136
页数：5
相关论文
共 50 条
  • [31] Infliximab and the bone in Crohn's disease
    Kunisaki, R
    Chaki, O
    Taguchi, T
    Sugiyama, T
    Sugita, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (06) : 789 - 790
  • [32] Halting infliximab in Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (09): : 793 - 793
  • [33] Infliximab: Is it a 5-ASA and antibiotics sparing drug in Crohn's disease?
    Fleisher, MR
    Rubin, SD
    Levine, AE
    Burns, AWR
    GASTROENTEROLOGY, 2003, 124 (04) : A527 - A527
  • [34] Choosing Wisely revisited: Finally the support we have been waiting for in geriatrics
    Resnick, Barbara
    GERIATRIC NURSING, 2015, 36 (02) : 91 - 94
  • [35] Climate action: is coronavirus what we have been waiting for? (and now what?)
    Macedo, Pedro
    Santos, Filipe Duarte
    Tristan Pedersen, Jiesper
    Penha-Lopes, Gil
    LOCAL ENVIRONMENT, 2021, 26 (06) : 666 - 672
  • [36] Healing of Tonsillar Crohn's Disease With Infliximab
    Bao, Bo
    Harriott, Melissa
    Kroeker, Karen I.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (11) : XXXI - XXXII
  • [37] Guidelines for treatment with infliximab for Crohn's disease
    Hommes, D. W.
    Oldenburg, B.
    van Bodegraven, A. A.
    van Hogezand, R. A.
    de Jong, D. J.
    Romberg-Camps, M. J. L.
    van der Woude, J.
    Dijkstra, G.
    NETHERLANDS JOURNAL OF MEDICINE, 2006, 64 (07): : 219 - 229
  • [38] Treatment of vulval Crohn's disease with infliximab
    Preston, PW
    Hudson, N
    Lewis, FM
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2006, 31 (03) : 378 - 380
  • [39] Infliximab for the treatment of orofacial Crohn's disease
    Mahadevan, U
    Sandborn, WJ
    INFLAMMATORY BOWEL DISEASES, 2001, 7 (01) : 38 - 42
  • [40] Commentary: infliximab or adalimumab in Crohn's disease?
    Sprakes, M. B.
    Hamlin, P. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (04) : 398 - 398
12345